• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发热性中性粒细胞减少症的变化面貌——从单一疗法到霉菌感染再到粘膜炎。为何采用经验性治疗?

The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?

作者信息

Klastersky Jean

机构信息

Department of Medicine, Institut Jules Bordet, 1000 Brussels, Belgium.

出版信息

J Antimicrob Chemother. 2009 May;63 Suppl 1:i14-5. doi: 10.1093/jac/dkp075.

DOI:10.1093/jac/dkp075
PMID:19372173
Abstract

Why empirical therapy? Because it works! Empirical antimicrobial therapy is a reasonable, pragmatic approach to limit the ominous threat of Gram-negative sepsis in febrile neutropenic cancer patients. Empirical treatment of occult fungal infection in patients with neutropenia and persistent fever, in spite of initial broad-spectrum antimicrobial coverage, is effective but the role of pre-emptive treatment remains to be established.

摘要

为什么采用经验性治疗?因为它有效!经验性抗菌治疗是一种合理、务实的方法,可限制发热性中性粒细胞减少癌症患者革兰氏阴性菌败血症的严重威胁。尽管初始给予了广谱抗菌覆盖,但对中性粒细胞减少且持续发热患者的隐匿性真菌感染进行经验性治疗是有效的,不过抢先治疗的作用仍有待确定。

相似文献

1
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?发热性中性粒细胞减少症的变化面貌——从单一疗法到霉菌感染再到粘膜炎。为何采用经验性治疗?
J Antimicrob Chemother. 2009 May;63 Suppl 1:i14-5. doi: 10.1093/jac/dkp075.
2
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.发热性中性粒细胞减少症的变化面貌——从单一疗法到霉菌感染再到黏膜炎。总结与评论。
J Antimicrob Chemother. 2009 May;63 Suppl 1:i41-3. doi: 10.1093/jac/dkp082.
3
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here?发热性中性粒细胞减少症的变化面貌——从单一疗法到霉菌感染再到粘膜炎。我们从这里何去何从?
J Antimicrob Chemother. 2009 May;63 Suppl 1:i16-7. doi: 10.1093/jac/dkp076.
4
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why monotherapy?
J Antimicrob Chemother. 2009 May;63 Suppl 1:i18-20. doi: 10.1093/jac/dkp077.
5
[Antimicrobial prophylaxis and therapy in neutropenia].[中性粒细胞减少症的抗菌预防与治疗]
Mycoses. 2003;46 Suppl 2:21-32.
6
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years.发热性中性粒细胞减少症的变化面貌——从单一疗法到霉菌感染再到黏膜炎。发热与中性粒细胞减少症:早期情况。
J Antimicrob Chemother. 2009 May;63 Suppl 1:i3-13. doi: 10.1093/jac/dkp074.
7
[Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].[循证医学概念在发热性中性粒细胞减少症治疗证据中的应用]
Enferm Infecc Microbiol Clin. 1999;17 Suppl 2:95-102.
8
Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.日本不明原因发热的中性粒细胞减少症患者管理临床指南:日本发热性中性粒细胞减少症研究组的验证
Int J Antimicrob Agents. 2005 Dec;26 Suppl 2:S123-7; discussion S133-40. doi: 10.1016/j.ijantimicag.2005.08.001. Epub 2005 Oct 24.
9
Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study.氟喹诺酮类和氟康唑预防用药的血液学患者中性粒细胞减少期间不明原因发热的亚胺培南 3 天治疗:一项前瞻性观察安全性研究。
Eur J Cancer. 2009 Nov;45(16):2810-7. doi: 10.1016/j.ejca.2009.06.025. Epub 2009 Aug 3.
10
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Management of mycoses in neutropenic patients: a brief history, 1960-2008.发热性中性粒细胞减少症的变迁——从单一疗法到霉菌感染再到黏膜炎。中性粒细胞减少患者真菌病的管理:简史,1960 - 2008年。
J Antimicrob Chemother. 2009 May;63 Suppl 1(Suppl 1):i23-6. doi: 10.1093/jac/dkp079.

引用本文的文献

1
Clinical Outcome of Febrile Neutropenia and Associated Factors Among Adult Patients with Cancer Treated at Ethiopian Oncology Centers: A Retrospective Observational Study.埃塞俄比亚肿瘤中心接受治疗的成年癌症患者发热性中性粒细胞减少症的临床结局及相关因素:一项回顾性观察研究
Oncol Ther. 2025 Jul 16. doi: 10.1007/s40487-025-00356-0.
2
Augmented Renal Clearance and Hypoalbuminemia-Induced Low Vancomycin Trough Concentrations in Febrile Neutropenic Patients With Hematological Malignancies.血液系统恶性肿瘤发热性中性粒细胞减少患者的肾清除率增加及低白蛋白血症导致万古霉素谷浓度降低
Cureus. 2022 Sep 25;14(9):e29568. doi: 10.7759/cureus.29568. eCollection 2022 Sep.
3
Identification and Distribution of Pathogens in a Major Tertiary Hospital of Indonesia.
印度尼西亚一家大型三级医院病原体的鉴定与分布
Front Public Health. 2020 Jan 31;7:395. doi: 10.3389/fpubh.2019.00395. eCollection 2019.
4
Time to antibiotics and outcomes in cancer patients with febrile neutropenia.癌症发热性中性粒细胞减少症患者使用抗生素的时机与治疗结果
BMC Health Serv Res. 2014 Apr 10;14:162. doi: 10.1186/1472-6963-14-162.
5
Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia.发热性中性粒细胞减少症的诊断与经验性抗生素治疗共识
Pediatr Rep. 2011 Feb 24;3(1):e4. doi: 10.4081/pr.2011.e4.